Cigna's Strong Performance Across Businesses Drive Q1 Earnings Beat; Raises 2021 Guidance

  • Cigna Corp CI reports Q1 total revenues of $41.9 billion, slightly ahead of the consensus of $40.2 billion, reflecting strong contributions from each of Cigna's ongoing businesses.
  • Q1 Adjusted EPS of $4.73 compared with $4.69 a year ago beat the $4.38 consensus. GAAP EPS improved to $3.30 from $3.15 a year ago.
  • The pharmacy customer base grew to 101.0 million, up 28% Y/Y, and an organic increase of 2.2 million YTD, driven by strong ongoing retention and new sales.
  • The total medical customer base reached 16.7 million, increasing 30,000 customers YTD, though down 3% Y/Y.
  • The growth was driven by Individual business, Select segment, and Medicare Advantage, partially offset by Commercial disenrollment throughout the quarter.
  • Evernorth adjusted revenues increased 13% Y/Y $30.6 billion driven by strong organic growth, including growth in retail network and specialty pharmacy services.
  • Cigna fulfilled 393 million adjusted pharmacy scripts, an increase of 9% Y/Y.
  • U.S. Medical adjusted revenues grew 5% to $10.4 billion, reflecting customer growth in Medicare Advantage, the Individual business, and the Select Segment, as well as premium increases and favorable net investment income.
  • The debt-to-capitalization ratio was 39.9%, in line with the long-term target of approximately 40%.
  • The SG&A expense ratio was 8.0%, a decrease from 8.5% from Q1 2020, driven by revenue growth, continued expense efficiency, and the repeal of the health insurance industry tax.
  • Guidance: Cigna sees FY21 sales of at least $166 billion versus $165.76 billion consensus, with Adjusted EPS of at least $20.2 versus the consensus of $20.26. This outlook includes approximately $1.25 per share in net unfavorable impacts of COVID-19.
  • It anticipates total Medical Customer Growth (lives) of at least 350,000.
  • Price Action: CI shares closed 0.6% lower at $256.93 on Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!